Table 4. Erection Problems Through 24 and 48 Months by Treatment Group for Those With Erection Problems at Baseline
|
Acebutolol, n (%) |
Amlodipine, n (%) |
Chlorthalidone, n (%) |
Doxazosin, n (%) |
Enalapril, n (%) |
P (4 df) |
Placebo, n (%) |
|
| Through 24-mo visit |
|
|
|
|
|
|
|
| Problem obtaining or maintaining erection |
4 (30.8) |
5 (45.5) |
4 (36.4) |
0 (0.0) |
4 (50.0) |
.229 |
6 (46.2) |
| P vs placebo |
.34 |
.43 |
.99 |
.039 |
.57 |
|
|
| With problems at baseline, n |
13 |
11 |
11 |
8 |
8 |
|
13 |
| Through 48-mo visit |
|
|
|
|
|
|
|
| Problem obtaining or maintaining erection |
5 (38.5) |
5 (45.5) |
5 (45.5) |
1 (12.5) |
6 (75.0) |
.278 |
6 (42.9) |
| P vs placebo |
.60 |
.43 |
.99 |
.16 |
.66 |
|
|
| Free of problems at baseline, n |
13 |
11 |
11 |
8 |
8 |
|
14 |
|
n indicates number with problems obtaining or maintaining erection.